Clinical Study in Medical Cannabis

In collaboration with Spectrum Thérapeutique

CMIE, in collaboration with Spectrum Thérapeutique, is conducting a clinical study in medical cannabis and chronic pain management.  

For more details, please contact us by email at or by phone at (450) 332-2430.  

How do I know if this study is for me?

Inclusion criteria:

  1. Subject is at least 25 years old with a diagnosis of chronic non-cancer pain.  
  1. Subject is, in the opinion of the physician, a candidate for medical cannabis treatment. Candidate status will be determined based on local regulations, current clinical practice, available guidelines and scientific literature, and the physician’s expertise or experience with medical cannabis products.  
  1. The subject has received a prescription/license for a product in the medical channel from Spectrum Thérapeutique.  
  1. Subject is able to read and understand the informed consent form and complete the study  


Exclusion criteria:

  1. Subject refuses to give informed consent or participate in any aspect of the study.  
  1.  Subject is pregnant or breastfeeding.  
  1.  Subject has a history of psychosis or schizophrenia (or other significant psychiatric disorder) including first degree relatives.  
  1. Subject has suspected or confirmed cardiovascular disease.  
  1. The subject is a liver transplant recipient or has severely compromised liver function. 


Information and Consultation

What patients are saying

Subscribe to CMIE newsletters

Join our email list to be the first to know about CMIE news and developments

Scroll to Top